Lukas Jeker։ Making Genomic Medicine Affordable for More Patients
Lukas Jeker, Assistant Professor Experimental Transplantation Immunology and Nephrology at University Hospital Basel, shared a post on LinkedIn about a recent article by Fyodor Urnov and Sadik Kassim, published in Nature։
”Very thoughtful words from Fyodor Urnov and Sadik Kassim.
Time and costs to perform safety and efficacy testing are key obstacles that prevent more genome-editing therapies to benefit patients.
Fyodor and Sadik outline 4 key aspects that need to change to move faster, cut costs and scale.
I hope they are correct that costs can be cut dramatically and I hope successful deployment will convince other regulators to adopt similar regulatory frameworks.
Some of the article is US-centric but similar principles can be applied to other legislations.
Some principles will be universal (mainly scientific), others will need local adaptation, and maybe someone can further improve the approach?
Looking forward to what’s to come.
Thanks Fyodor and Sadik (and the many others who are pioneering such treatments) for your energy to bring change.
The last paragraph is particularly strong!
Read it (including the dollar COI disclosure).
I hope there will be a time when we look back and say: yes, there was a time when genomic medicine was unaffordable for most people.
Personalized CRISPR therapies could soon reach thousands – here’s how.”
Title: Personalized CRISPR therapies could soon reach thousands — here’s how
Authors: Fyodor D. Urnov, Sadik H. Kassim

Stay updated with Hemostasis Today.
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials